Mechanisms of host defense following severe acute respiratory syndrome-coronavirus (SARS-CoV) pulmonary infection of mice

Journal of Immunology

Volumn 173, Issue 6, 2004, Pages 4030-4039

  Glass, William G ^a   Subbarao, Kanta ^a   Murphy, Brian ^a   Murphy, Philip M ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD1 ANTIGEN; CHEMOKINE; CHEMOKINE RECEPTOR CXCR3; CXCL9 CHEMOKINE; DIPEPTIDYL CARBOXYPEPTIDASE; GAMMA INTERFERON INDUCIBLE PROTEIN 10; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MONOCYTE CHEMOTACTIC PROTEIN 1; RAG1 PROTEIN; RANTES; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; B LYMPHOCYTE; BRAIN INFECTION; CONTROLLED STUDY; CYTOKINE RELEASE; FAILURE TO THRIVE; HOST RESISTANCE; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; LUNG INFECTION; MOUSE; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SARS CORONAVIRUS; SEVERE ACUTE RESPIRATORY SYNDROME; TH1 CELL; TH2 CELL; VIRUS ISOLATION; VIRUS REPLICATION; WEIGHT GAIN;

EID: 4644249090     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.173.6.4030     Document Type: Article

References (47)

1. Rota, P. A., M. S. Oberste, S. S. Monroe, W. A. Nix, R. Campagnoli, J. P. Icenogle, S. Penaranda, B. Bankamp, K. Maher, M. H. Chen, et al. 2003. Characterization of a novel coronavirus associated with severe acute respiratory syndrome. Science 300:1394.
2. Fouchier, R. A., T. Kuiken, M. Schutten, G. van Amerongen, G. J. van Doomum, B. G. van den Hoogen, M. Peiris, W. Lim, K. Stohr, and A. D. Osterhaus. 2003. Aetiology: Koch's postulates fulfilled for SARS virus. Nature 423:240.
3. Drosten, C., S. Gunther, W. Preiser, S. van der Werf, H. R. Brodt, S. Becker, H. Rabenau, M. Panning, L. Kolesnikova, R. A. Fouchier, et al. 2003. Identification of a novel coronavirus in patients with severe acute respiratory syndrome. N. Engl. J. Med. 348:1967.
4. Snijder, E. J., P. J. Bredenbeek, J. C. Dobbe, V. Thiel, J. Ziebubr, L. L. Poon, Y. Guan, M. Rozanov, W. J. Spaan, and A. E. Gorbalenya. 2003. Unique and conserved features of genome and proteome of SARS-coronavirus, an early split-off from the coronavirus group 2 lineage. J. Mol. Biol. 331:991.
5. Folz, R. J., and M. A. Elkordy. 1999. Coronavirus pneumonia following autologous bone marrow transplantation for breast cancer. Chest 115:901.
6. El-Sahly, H. M., R. L. Atmar, W. P. Glezen, and S. B. Greenberg. 2000. Spectrum of clinical illness in hospitalized patients with "common cold" virus infections. Clin. Infect. Dis. 31:96.
7. Manocha, S., K. R. Walley, and J. A. Russell. 2003. Severe acute respiratory distress syndrome (SARS): a critical care perspective. Crit. Care Med. 31:2684.
8. Choi, K. W., T. N. Chau, O. Tsang, E. Tso, M. C. Chiu, W. L. Tong, P. O. Lee, T. K. Ng, W. F. Ng, K. C. Lee, et al. 2003. Outcomes and prognostic factors in 267 patients with severe acute respiratory syndrome in Hong Kong. Ann. Intern. Med. 139:715.
9. Towler, P., B. Staker, S. G. Prasad, S. Menon, J. Tang, T. Parsons, D. Ryan, M. Fisher, D. Williams, N. A. Dales, et al. 2004. ACE2 x-ray structures reveal a large hinge-bending motion important for inhibitor binding and catalysis. J. Biol. Chem. 279:17996.
10. Wang, P., J. Chen, A. Zheng, Y. Nie, X. Shi, W. Wang, G. Wang, M. Luo, H. Liu, L. Tan, et al. 2004. Expression cloning of functional receptor used by SARS coronavirus. Biochem. Biophys. Res. Commun. 315:439.
11. Prabakaran, P., X. Xiao, and D. S. Dimitrov. 2004. A model of the ACE2 structure and function as a SARS-CoV receptor. Biochem. Biophys. Res. Commun. 314:235.
12. Li, W., M. J. Moore, N. Vasilieva, J. Sui, S. K. Wong, M. A. Berne, M. Somasundaran, J. L. Sullivan, K. Luzuriaga, T. C. Greenough, et al. 2003. Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus. Nature 426:450.
13. Haagmans, B. L., T. Kuiken, B. E. Martina, R. A. Fouchier, G. F. Rimmelzwaan, G. Van Amerongen, D. Van Riel, T. De Jong, S. Itamura, K. H. Chan, et al. 2004. Pegylated interferon-α protects type 1 pneumocytes against SARS coronavirus infection in macaques. Nat. Med. 10:290.
14. Martina, B. E., B. L. Haagmans, T. Kuiken, R. A. Fouchier, G. F. Rimmelzwaan, G. Van Amerongen, J. S. Peiris, W. Lim, and A. D. Osterhaus. 2003. Virology: SARS virus infection of cats and ferrets. Nature 425:915.
15. Subbarao, K., J. McAuliffe, L. Vogel, G. Fahle, S. Fischer, K. Tatti, M. Packard, W. J. Shieh, S. Zaki, and B. Murphy. 2004. Prior infection and passive transfer of neutralizing antibody prevent replication of severe acute respiratory syndrome coronavirus in the respiratory tract of mice. J. Virol. 78:3572.
16. Ksiazek, T. G., D. Erdman, C. S. Goldsmith, S. R. Zaki, T. Peret, S. Emery, S. Tong, C. Urbani, J. A. Comer, W. Lim, et al. 2003. A novel coronavirus associated with severe acute respiratory syndrome. N. Engl. J. Med. 348:1953.
17. McClane, B. A., A. P. Wnek, and P. Whitaker-Dowling. 1987. Interferon pretreatment enhances the sensitivity of Vero cells to Clostridium perfringens type A enterotoxin. Microb. Pathog. 3:195.
18. Crespi, M., M. N. Chiu, J. K. Struthers, B. D. Schoub, and S. F. Lyons. 1988. Effect of interferon on Vero cells persistently infected with Sendai virus compared to Vero cells persistently infected with SSPE virus. Arch. Virol. 98:235.
19. Kramer, M. J., R. Dennin, C. Kramer, G. Jones, E. Connell, N. Rolon, A. Gruarin, R. Kale, and P. W. Trown. 1983. Cell and virus sensitivity studies with recombinant human α interferons. J. Interferon Res. 3:425.
20. Tonew, M., and B. Gluck. 1986. Interferon sensitivity of various cell lines. J. Basic Microbiol. 26:173.
21. Li, X. W., R. M. Jiang, J. Z. Guo, and Q. Y. Wang. 2003. Clinical analysis of SARS: 27 cases report. Zhonghua Yi Xue Za Zhi 83:910.
22. Hui, D. S., P. C. Wong, and C. Wang. 2003. SARS: clinical features and diagnosis. Respirology 8(Suppl.):S20.
23. Grant, M. 2002. Secondary persistent infection with hepatitis C virus: a challenge for adaptive immunity. Lancet 359:1452.
24. Mahanty, S., K. Hutchinson, S. Agarwal, M. McRae, P. E. Rollin, and B. Pulendran. 2003. Cutting edge: impairment of dendritic cells and adaptive immunity by Ebola and Lassa viruses. J. Immunol. 170:2797.
25. Diamond, M. S. 2003. Evasion of innate and adaptive immunity by flaviviruses. Immunol. Cell Biol. 81:196.
26. Siegal, F. P., C. Lopez, P. A. Fitzgerald, K. Shah, P. Baron, I. Z. Leiderman, D. Imperato, and S. Landesman. 1986. Opportunistic infections in acquired immune deficiency syndrome result from synergistic defects of both the natural and adaptive components of cellular immunity. J. Clin. Invest. 78:115.
27. Cinatl, J., B. Morgenstern, G. Bauer, P. Chandra, H. Rabenau, and H. W. Doerr. 2003. Treatment of SARS with human interferons. Lancet 362:293.
28. Slauson, D. O., J. C. Lay, W. L. Castleman, and N. R. Neilsen. 1987. Alveolar macrophage phagocytic kinetics following pulmonary parainfluenza-3 virus infection. J. Leukocyte Biol. 41:412.
29. Contigiani, M. S., S. I. Medeot, G. E. Diaz, and M. S. Sabattini. 1991. Rapid vascular clearance of two strains of Junin virus in Calomys musculinus: selective macrophage clearance. Acta Virol. 35:144.
30. + T lymphocytes and macrophage subsets in the control of a generalized virus infection. J. Virol. 70:8301.
31. Wong, C. K., C. W. Lam, A. K. Wu, W. K. Ip, N. L. Lee, I. H. Chan, L. C. Lit, D. S. Hui, M. H. Chan, S. S. Chung, and J. J. Sung. 2004. Plasma inflammatory cytokines and chemokines in severe acute respiratory syndrome. Clin. Exp. Immunol. 136:95.
32. Gasperini, S., M. Marchi, F. Calzetti, C. Laudanna, L. Vicentini, H. Olsen, M. Murphy, F. Liao, J. Farber, and M. A. Cassatella. 1999. Gene expression and production of the monokine induced by IFN-γ (MIG), IFN-inducible T cell α chemoattractant(I-TAC), and IFN-γ-inducible protein-10 (IP-10) chemokines by human neutrophils. J. Immunol. 162:4928.
33. Yang, Z. Y., W. P. Kong, Y. Huang, A. Roberts, B. R. Murphy, K. Subbarao, and G. J. Nabel. 2004. A DNA vaccine induces SARS coronavirus neutralization and protective immunity in mice. Nature 428:561.
34. Bisht, H., A. Roberts, L. Vogel, A. Bukreyev, P. L. Collins, B. R. Murphy, K. Subbarao, and B. Moss. 2004. Severe acute respiratory syndrome coronavirus spike protein expressed by attenuated vaccinia virus protectively immunizes mice. Proc. Natl. Acad. Sci. USA 101:6641.
35. Li, Z., X. Guo, W. Hao, Y. Wu, Y. Ji, Y. Zhao, F. Liu, and X. Xie. 2003. The relationship between serum interleukins and T-lymphocyte subsets in patients with severe acute respiratory syndrome. Chin. Med. J. (Engl.). 116:981.
36. Jones, B. M., E. S. Ma, J. S. Peiris, P. C. Wong, J. C. Ho, B. Lam, K. N. Lai, and K. W. Tsang. 2004. Prolonged disturbances of in vitro cytokine production in patients with severe acute respiratory syndrome (SARS) treated with ribavirin and steroids. Clin. Exp. Immunol. 135:467.
37. Xie, J., Y. Han, T. S. Li, Z. F. Qiu, X. J. Ma, H. W. Fan, W. Lu, Z. Y. Liu, Z. Wang, H. L. Wang, and G. H. Deng. 2003. Dynamic changes of plasma cytokine levels in patients with severe acute respiratory syndrome. Zhonghua Nei Ke Za Zhi 42:643.
38. Thiel, V., K. A. Ivanov, A. Putics, T. Hertzig, B. Schelle, S. Bayer, B. Weissbrich, E. J. Snijder, H. Rabenau, H. W. Doerr, et al. 2003. Mechanisms and enzymes involved in SARS coronavirus genome expression. J. Gen. Virol. 84:2305.
39. Zhang, R., Z. Guo, J. Lu, J. Meng, C. Zhou, X. Zhan, B. Huang, X. Yu, M. Huang, X. Pan, et al. 2003. Inhibiting severe acute respiratory syndrome-associated coronavirus by small interfering RNA. Chin. Med. J. (Engl.). 116:1262.
40. Collazos, J. 2003. Opportunistic infections of the CNS in patients with AIDS: diagnosis and management. CNS Drugs 17:869.
41. Diamond, M. S., B. Shrestha, A. Marri, D. Mahan, and M. Engle. 2003. B cells and antibody play critical roles in the immediate defense of disseminated infection by West Nile encephalitis virus. J. Virol. 77:2578.
42. Hung, E. C., S. S. Chim, P. K. Chan, Y. K. Tong, E. K. Ng, R. W. Chiu, C. B. Leung, J. J. Sung, J. S. Tam, and Y. M. Lo. 2003. Detection of SARS coronavirus RNA in the cerebrospinal fluid of a patient with severe acute respiratory syndrome. Clin. Chem. 49:2108.
43. He, L., Y. Q. Ding, X. Y. Che, Q. L. Zhang, Z. X. Huang, H. J. Wang, H. Shen, Z. G. Li, J. J. Cai, J. H. Zhang, et al. 2003. Expression of the monoclonal antibody against nucleocapsid antigen of SARS-associated coronavirus in autopsy tissues from SARS patients. Di Yi Jun Yi Da Xue Xue Bao 23:1128.
44. Zhang, Q. L., Y. Q. Ding, J. L. Hou, L. He, Z. X. Huang, H. J. Wang, J. J. Cai, J. H. Zhang, W. L. Zhang, J. Geng, et al. 2003. Detection of severe acute respiratory syndrome (SARS)-associated coronavirus RNA in autopsy tissues with in situ hybridization. Di Yi Jun Yi Da Xue Xue Bao 23:1125.
45. Yang, J., Z. H. Wang, J. J. Chen, and J. L. Hou. 2003. Clinical detection of polymerase gene of SARS-associated coronavirus. Di Yi Jun Yi Da Xue Xue Bao 23:424.
46. Ren, Y., H. G. Ding, Q. F. Wu, W. J. Chen, D. Chen, Z. Y. Bao, L. Yang, C. H. Zhao, and I. Wang. 2003. Detection of SARS-CoV RNA in stool samples of SARS patients by nest RT-PCR and its clinical value. Zhongguo Yi Xue Ke Xue Yuan Xue Bao 25:368.
47. Ding, Y., H. Wang, H. Shen, Z. Li, J. Geng, H. Han, J. Cai, X. Li, W. Kang, D. Weng, et al. 2003. The clinical pathology of severe acute respiratory syndrome (SARS): a report from China. J. Pathol. 200:282.